
The new Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) has a number of important updates and changes made to major depression (also known as clinical depression) and depressive disorders. This article outlines some of the major changes to these conditions, including the introduction of two new disorders: disruptive mood dysregulation disorder and premenstrual dysphoric disorder.
Dysthymia is gone, replaced with something called "persistent depressive disorder." The new condition includes ...

While sleeping pills have been around for a long time, the modern age of hypnotics began December 16, 1992, when the FDA approved
Ambien (zolpidem).
Sonata (zaleplon), a late bloomer, received approval in 1999.
Both Ambien and Sonata are officially classified as "non-benzodiazepines," although they do their pharmaco- slumbering magic on the same site as the benzodiazepines (BZs), namely by binding to the GABAA/ benzodiazepine/chloride channel receptor complex. However, the non-BZs bind more selectively to ...

You're a cutting edge psychiatrist. Not only are you great with meds, but you have a passing knowledge of CBT (cognitive-behavior therapy) techniques for the treatment of OCD.
Sorry. You're already behind the curve. "ERP," and not CBT, are the current hot initials when discussing therapy for OCD.
ERP stands for "exposure with response prevention," and it is hands-down the most effective non-drug approach to treating OCD. And many would argue that it is superior to ...